KYMERA THERAPEUTICS, INC.: cashflow_investing

Value{"amount": -330607000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2024-01-01 – 2024-03-31
Statuscurrent
EntityKYMERA THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-24-051567 · Open the official SEC filing →
Retrieved: 2026-08-19T18:15:33.181497+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001815442/cashflow-investing/2024-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/1e4e37dd-0c70-4a55-810f-2d27bdf98c01

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies